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ABSTRACT 
Objective: The present study aims to model and optimize the compression process of the Albendazole 400 mg tablets of a pharmaceutical industry 
production line to increase the production speed (tablets/h) while maintaining quality requirements. 
Methods: The study was conducted using the Design of Experiments (DoE) methodology to identify and correlate the critical parameters during the 
process that affect the maintenance of the compression speed. In order to support the experiments, was tested disintegration time, average 
hardness, hardness variation, average weight, and friability. 
Results: Was obtained that quality attributes of disintegration and friability did not generate a significant model but it has been established 
correlations between Fill-O-Matic speed and main compression force in the responses of weight variation, hardness, and mean hardness. It was 
found that the main compression force between 6 to 9 kN, the pre-compression force of 1,965 to 5,615 kN, and the speed of 55 RPM for Fill-O-Matic 
speed are responsible for ensuring that all quality attributes analyzed remain within the expected specification. 
Conclusion: It was possible to apply the Design of Experiment (DoE) methodology in the compression process of the drug Albendazole 400 mg and 
to evaluate the impact of the parameters of this step on the formation of the tablet to significantly increasing the productivity of this product. The 
Fill-O-Matic speed parameter was the main control factor discovered in this study to maintain quality attributes. 
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INTRODUCTION  
The tablet is the most consumed and produced pharmaceutical form in 
the world. This fact is possibly justified by the greater chemical stability 
of the tablets when compared to other dosage forms. Besides that, they 
are more convenient to handle and are mostly administered orally. Also, 
tablets can be produced on a fast and extremely reproducible industrial 
scale, with highly controlled quality attributes [1]. 
The compression process used in the manufacture of tablets is given 
by the literal compression of a quantity of powder within the die 
cavity of a tablet press machine. The procedure is basically divided 
into 3 sub-steps: die cavity filling, tablet production with punches 
moving within the die, thereby compressing powder into the desired 
tablets (compression), and ejection of the tablet. Even though it 
looks like a simple process, today's tablet press machines provide a 
huge range of parameters in order to increase process control and, 
in turn, enable the production of tablets at a high speed [1, 2].  
When evaluated individually, the compression stage has a direct 
influence on some quality attributes required for a tablet, such as 
disintegration and dissolution times, hardness, friability, and mean 
weight. Thus, a more detailed study on this process is justified to 
maintain the quality, safety, and efficacy of the medication, while not 
ignoring the pharmaceutical industry's constant search for increased 
productivity [2, 3]. 
However, during the development of a drug, it is common to focus 
more on defining the formulation than on the parameters to be used 
in unit operations. It is not uncommon to encounter problems when 
transferring technology (Scale-up), since the formulation is often 
defined on a laboratory scale and aiming to meet specific quality 
attributes while ignoring factors such as productivity. In addition to 
the fact that regulatory agencies are progressively increasing the 
requirements for registration and post-registration of medicines, the 
use of a statistical-based approach in the development or re-
development of a product brings greater security and robustness to 
the production routine and reduces the need for any eventual 
change in the production process [4, 5]. 
In this context, agencies and institutions such as the Food and Drug 
Administration (FDA) and Internation Council for Harmonization 
(ICH), have been publishing guides and regulations that encourage 
the application of the Design of Experiments (DoE) concept and, 
using it, to implement the statistical methodology of response 
surface analysis, in order to provide the pharmaceutical industry 
with ways to obtain greater knowledge about their products, leading 
to the development of more robust and reproducible processes. In 
ICH 8, published in 2009, it is already possible to find information on 
design space or “workspace”, where ranges of production 
parameters and/or characteristics of the raw material are tested, 
correlating them with impacts on quality attributes. In this way, it is 
possible to know which variations our process is capable of 
withstanding so that the finished product still remains approved in 
the quality control tests [5, 6]. 
The application of DoE is important to discover the individual 
and/or combined influence of the changed parameters. In recent 
years, there has been an increasing amount of literature showing the 
applicability of this statistical methodology in the pharmaceutical 
industry [7-11] and, more specifically, in the compression stage [12-
16]. In the work of Garlapati and Roi (2017), using statistical 
modeling, the authors were able to define the tablet press regulation 
parameters that best met the quality attributes of Levocetirizine 
tablet formulation [17]. Iancu et al. (2016) performed a similar 
series of experiments on Diclofenac Sodium orodispersible tablets to 
find the compression force that provided the best friability, 
disintegration time, wetting time, and hardness values [18]. 
Therefore, the purpose of this investigation was, using the Design of 
Experiment (DoE) methodology, to model and optimize the 
compression stage of the granulate produced by wet way of the 
Albendazole 400 mg in the form of chewable tablets. Albendazole is 
the newest carbamate in the benzimidazole group. The drug is 
indicated mainly for intestinal nematodes and cestodes. Such a 
product has a global presence, being one of the most used drugs for 
the treatment of parasitic infections [19]. 
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In a pharmaceutical industry located in southern Brazil, the 
compression stage of this antiparasitic is time-consuming. The 
maximum validated compressing speed is about 10 RPM. Assessing 
the productive records of this medicine, it was found that, during 
previous tests aiming at increasing the compression speed, problems 
arose such as the variation in weight and hardness, both exceeding the 
control and specification limits. This study, therefore, set out to assess 
the effect of compression phase parameters to increase the production 
speed (tablets/h) while maintaining quality requirements. 
MATERIALS AND METHODS  
Experimental design 
Design-Expert version 7.1.3 software was used for the experimental 
design and statistical analysis [20]. Using ICH 8, 9, and 10 as a base, 
we have defined the following parameters for controlling the 
compression: Fill-O-Matic (FOM) Force Feeder Speed, Pre-
Compression, and Main Compression forces. As response variables, 
the so-called quality attributes necessary for process control in the 
compression stage; the following attributes were used: Friability, 
Disintegration Time, Hardness, Relative Hardness Variation, and 
Weight Variation. 
To assess the compression parameters influence on the response 
factors, we used an experimental 23
 
complete factorial design (CFD) 
plus 3 central points, resulting in a total of 11 experiments. The 
ranges of the parameters as well as the response factors used for 
both experiments are shown in table 1. During the test, the 
compression speed was kept constant, at 63 RPM. The significance of 
the model and the tested factors were calculated using Analysis of 
Variance (ANOVA) statistical methodology with a significance level 
of 95% [21]. 
Table 1: Values of the parameters and response variables used in the compression stage 
Compression parameters Ranges Quality attributes Desired response 
-1 0 1 
Fill-O-Matic Speed 25 RPM 40 RPM 55 RPM Friability <1,5 %* 
Pre-compression Force 1,965 kN 3,79 kN 5,615 kN Disintegration Time <1800 s* 
Main Compression Force 3,0 kN 6,5 kN 10 kN Hardness 09-15 kp 
 Relative Hardness Variation <practicable 
Weight Variation <5% 
(*) Brazilian Pharmacopoeia [22] 
 
Materials 
The inputs used were: Lactose (Friesland Campina DMV Bv), Talc (SKC 
Inc), Corn Starch (Cargill Agrícola SA), Saccharin Sodium (Tiankin 
North Food Co, Inc), Magnesium Stearate (Itacel Farmoquímica Inc), 
Microcrystalline Cellulose (Itacel Farmoquímica Inc), Sodium 
Amidoglycolate (Itacel Farmoquímica Inc), Povidone 30 (Ashland 
Speciality Ingredients), Croscarmellose Sodic (Itacel Farmoquímica 
Inc), Micronized Albendazole (Punjab Chemical and Crop Protection), 
Sodium Laurilsulfate (Volp Inc) and Aerosil (Evonik Degussa Brasil 
Inc). The necessary materials, as well as the equipment used to 
manufacture the tablets, were provided by the company. The 
proportions were omitted because it is an industrial secret. 
Dry mix 
The ingredients were weighed and then sieved using a 1.5 mm mesh 
sieve. The inputs, already sieved, were mixed in the High Shear 
Comasa RD edition for 4 min with the impeller at 80 RPM. 
Granulation 
The agglutinating solution for granulation was prepared by adding 
the inputs from that stage to the water under constant agitation of 
the mechanical stirrer (IKA RW 20) at 300 RPM. After the 
ingredients are completely dissolved, was added the prepared 
solution to the dough under mixing with the impeller at 80 RPM. At 
the end of the addition, the chipper was activated at 3000 RPM for 2 
min to standardize the granulate formed. 
Drying 
Drying was carried out in the Comasa RD Developer fluidized bed. 
The inlet temperature used was 50 °C. The process took about 40 
min until the granules reach the desired humidity range, between 
2.5-3.5%. 
Calibration and external phase 
After drying, granulate was calibrated in a benchtop granulator at 
300 RPM speed through a 1.0 mm mesh sieve. The preparation of the 
external phase was carried out in a benchtop mixer (Bin Mixer 
SaintyCo). The granulate was added to the Bin, followed by the 
inputs, except for magnesium stearate and colloidal silicon dioxide, 
previously sieved manually in a 1.0 mm mesh sieve. The mixing took 
place for 10 min at 8 RPM. Afterward, the lubricants sieved in a sieve 
with 0.5 mm mesh were added, mixing for 3 min at 8 RPM. 
Compression process 
The tablet compression took place in the Fette 102i tablet press 
machine using a rotor with 8 punches of 17 x 7.5 mm. The stage was 
started by adjusting the average tablet weight to 770 mg±5% and 
compression speed at 63 RPM. For each condition indicated in table 
1, all tablets formed within one minute were collected. The average 
weight was adjusted only at the beginning of the process; the 
compression parameters were adjusted independently and with the 
equipment stopped for each variable. 
Analysis of quality attributes 
Tests chosen to assess the impact of the compression parameters 
were all carried out based on the one described in the general 
methods of the Brazilian Pharmacopoeia [22]. 
Friability 
Friability analysis was executed with the weighing of 10 tablets by 
submitting them to the Erweka TAR 120/220 friabilometer for 4 min 
at 25 RPM. 
Disintegration time 
An Erweka ZT 320 disintegrator was used for this test. The water 
used as the immersion liquid was kept at 37±1 °C. Was used 6 pills in 
each vat and the time was recorded as soon as the last pill was 
completely disintegrated. The established time limit was 30 min. 
Hardness and relative hardness variation 
This test was performed with an Erweka durometer model THB 125. 
The mean and the relative amplitude, calculated by the difference of 
the minimum and maximum hardness of 10 tablets was determined, 
in addition to the calculation of the relative standard deviation. 
Average weight and weight variation 
Were weighed 20 tablets, individually on the scale (Metler Toledo-
AL204) with subsequent calculation of the standard deviation. The 
specification recommended by the Pharmacopoeia is a variation 
of±10% in relation to the ideal average weight. 
RESULTS AND DISCUSSION 
Table 2 shows the order of the experiments as well as the results 
obtained for each response variable. Analyzing the results, one can 
affirm that, by the programmed compression parameters, was 
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observed that there was an influence on the disintegration time. 
However, it was not possible the statistical correlation with the 
programmed parameters, a fact that was confirmed by the non-
significance of the model, indicated by the p-value greater than 0.05. 
In this test, the evaluated tablets took an average of 395 s for 
complete disintegration, with values of a minimum of 309 s and a 
maximum of 456 s. Such results are within the recommended by the 
Brazilian Pharmacopoeia, which specifies that the tablets should not 
take more than 1800 s to disintegrate [22]. The model's non-
significance was attributed mainly to two factors. First, the presence 
of sodium lauryl sulfate in the formulation, which has the function of 
increasing the active ingredient wettability, which in turn can lead to 
a lower disintegration time regardless of the hardness obtained. 
Second, the pre-compression and main compression force ranges 
may not have been wide enough to demonstrate a significant 
variation in the test [23]. 
 
Table 2: Complete factorial experimental design with 3 factors in 2 levels with 3 central points, as well as the results obtained for each 
response variable 
Run MCF (kN) SFOM (RPM) PCF (kN) DES (s) RHV (%) FRI (%) HAR (kp) WV (mg) 
1 6.5 40 3.79 369 0.169919 0.012 9.6 17.7291 
2 10 55 5.615 371 0.183783 0.049 15.6 17.99386 
3 3 25 5.615 456 0.30786 0.179 6.8 17.06729 
4 10 25 5.615 385 0.154417 0.01 15.35 22.42497 
5 6.5 40 3.79 427 0.191025 0.115 11.25 18.11983 
6 6.5 40 3.79 385 0.226189 0.095 11.25 18.56584 
7 3 55 1.965 427 0.12859 0.918 4.55 12.77506 
8 10 55 1.965 397 0.084606 0 16 10.49255 
9 3 25 1.965 309 0.278909 1.05 4.5 26.74043 
10 10 25 1.965 364 0.239973 0.075 14.8 20.03285 
11 3 55 5.615 452 0.135194 0.007 7.2 11.06578 
MCF = Main Compression Force, SFOM = FOM Speed, PCF = Pre-Compression Force, DES = Disintegration Time, RHV = Relative Hardness Variation, 
FRI = Friability, HAR = Hardness, WV = Weight Variation. 
 
The Friability response variable was impacted when the 
compression and pre-compression force parameters were changed. 
However, it was not possible to establish a statistical model to 
correlate the effects with the responses, since the p-value was above 
0.05. According to Masilungan and Kraus (1989), the correlation 
between strength parameters and friability is explicit, indicating the 
role of increasing hardness, to a certain extent, in decreasing 
friability [24]. 
Looking at table 2, it is possible to argue that, at least empirically, 
when the main compression force of 10 kN is exerted, the highest 
tested force, the average friability results are about 15 times lower 
when compared to that obtained using the lowest force, 3 kN. It is 
still possible to correlate the pre-compression force, because when 
applied at its highest tested value, 5.615 kN, there is also a positive 
impact on the friability values. 
The Weight Variation variable (WV), on the other hand, was directly 
impacted by the Fill-O-Matic Speed factor (SFOM) and by the 
interaction of Fill-O-Matic Speed, Main Compression Force, and Pre-
Compression Force factors. 
The data obtained through the analysis of variance (table 3) for the 
Weight Variation attribute showed normal behavior, the residues are 
distributed randomly around zero and there are no outliers. The values 
are arranged within the acceptable range (3σ to-3σ). The p-value of the 
model at 0.0020 and the F-value 83.28, as well as the non-significance of 
the Lack of Fit, indicate the significance for a linear model. 
 
Table 3: Analysis of variance (ANOVA) of the response variables, adopting a 95% confidence level 
Hardness (kp) SS DF MS F Value P-value prob>F S 
Model 187.21125 1 187.21125 170.604 <0.0001 significant 
 A-Main Compression 187.21125 1 187.21125 170.604 <0.0001  
Curvature 0.021818182 1 0.021818182 0.019883 0.8914 not significant 
Residual 8.77875 8 1.09734375    
Lack of Fit 6.96375 6 1.160625 1.278926 0.5008 not significant 
Pure Error 1.815 2 0.9075    
Cor Total 196.0118182 10     
Relative hardness variation (%) 
Model 0.025198653 1 0.025198653 10.1339 0.0129 significant 
 B–FOM Speed 0.025198653 1 0.025198653 10.1339 0.0129  
Curvature 9.3453E-05 1 9.3453E-05 0.037583 0.8511 not significant 
Residual 0.019892563 8 0.00248657    
Lack of Fit 0.018276507 6 0.003046084 3.769777 0.2245 not significant 
Pure Error 0.001616056 2 0.000808028    
Cor Total 0.045184669 10     
Weight variation (mg) 
Model 228.0499 6 38.00832 83.27746 0.0020 significant 
 A-Main Compression 1.357678 1 1.357678 2.974716 0.1830  
 B–FOM Speed 143.9761 1 143.9761 315.4562 0.0004  
 C-Pre-compression 0.277136 1 0.277136 0.607215 0.4927  
 AB 4.493217 1 4.493217 9.844783 0.0518  
 AC 56.58272 1 56.58272 123.9745 0.0016  
 BC 21.36312 1 21.36312 46.80728 0.0064  
Curvature 1.446227 1 1.446227 3.168729 0.1731 not significant 
Residual 1.369217 3 0.456406    
Lack of Fit 1.018638 1 1.018638 5.811164 0.1375 not significant 
Pure Error 0.35058 2 0.17529    
Cor Total 230.8654 10     
SS = Sum of Squares, DF = Degree of Freedom, MS = Mean Square, S = Significant  
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In fig. 1, the effect of changing the Fill-O-Matic Speed and Pre-
Compression force parameters on the Weight Variation response 
variable is demonstrated. The influence of FOM Speed on weight 
variation has already been mentioned in the literature. Some studies 
correlate the significance of this influence with the flow 
characteristics of the powder [25]. Free-flowing powders do not 
have a significant impact of the FOM Speed on quality attributes; 
however, for powders with less flow, the use of different speeds 
directly impacts quality attributes [26]. The drug chosen as a model 
for this study, Albendazole 400 mg, has the characteristic of a fine 
powder, even after granulation, since the active ingredient is 
micronized and is present in a large percentage in the formulation. 
Even not determining the flow properties, it is possible, visually, to 
assume that the material does not have a good/excellent flow. 
The model also indicated interactions between the Main Compression 
Force and Pre-Compression Force. When increasing the Main 
Compression Force, the Weight Variation increases when 5.615 kN of 
Pre-Compression force is applied. However, when the Pre-
Compression force was 1.965 kN the opposite effect was observed. 
 
 
Fig. 1: Impact of changing the FOM speed factor on the response to weight variation 
 
The interactions of other factors, such as the FOM Speed with the 
Pre-Compression force, do have an impact on the Weight Variation 
response variable, but they will not be considered in this discussion, 
due to the small influence they have on the effect, only 8.59% of the 
total. However, for the significance of the model, these factors were 
considered, as shown in the equation below. 
Weight variation = 51.276 − 2.031MCF − 0.602SFOM − 
5.196PCF+0.0142(MCF)(SFOM)+0.416(MCF)(PCF)+0.059(SFOM)(MCF) 
where: MCF = Main Compression Force, PCF = Pre-Compression 
Force e SFOM = Fill-O-Matic Speed. 
The variables of Hardness and Relative Hardness Variation were 
impacted by the Main Compression values chosen for the 
experimental design. 
Hardness was impacted by the change in the Main Compression Force, 
having a positive effect; that is, according to the increase in the main 
compression force, the data obtained by the experiment (fig. 2) 
showed normal behavior. The residues are randomly distributed 
around from zero and there are also no outliers with values within the 
acceptable range (3σ to-3σ). The p-value of the model at 0.0001 and 
the F-value of 170.60, as well as the non-significance of the Lack of Fit, 
indicate the significance for a linear model. 
It is possible to indicate the appropriate force range to comply with 
the specifications outlined in table 1. According to fig. 2, the force 
specification range should be between 6 at 9 kN in the Main 
Compression Force and, regardless of the force exerted in the pre-
compression phase, the resulting Hardness will be between 9-15 kp 
according to the model. This behavior is already easily found in the 
literature, where the greater the main compression force employed, 
the greater the resulting hardness. However, there is a breaking 
point where the tablet cannot increase the hardness any more 
regardless of the force used [27]. 
The equation that was provided by the model was represented 
below:  
Hardness = 1.616+1.382MCP 
where: MCF = Main Compression Force. 
Regarding the hardness variation, expressed by the Relative 
Hardness Variation response of each 20 tablets, it was possible 
during data analysis (table 3) to determine the negative relationship 
of the FOM Speed (fig. 2) in the hardness variation values. The 
higher the FOM Speed, the smaller the observed Hardness Variation, 
according to the model equation shown below. 
Hardness Variation = 0.339–3.741x10-3
where: SFOM = Fill-O-Matic Speed. 
SFOM 
The data obtained showed normality and random distribution 
around the zero axes, the residues remained within the expected 
range of 3 to-3 standard deviations, added to the p-value of the 
model 0.0129 and the non-significance of the Lack of Fit, we assume 
that the model built is significant. 
As can be seen from fig. 2, the FOM Speed significantly impacts the 
Relative Hardness Variation found. It can be established, therefore, 
that the 55 RPM FOM Speed is ideal within the values tested for the 
speed of 63 RPM of the tablet press rotor, since it presented lower 
values of weight variation as well as in hardness. 
After all the experiments, it can be seen that regardless of the factors 
used, the Disintegration Time and Friability remained within that 
specified in table 1. This way, the ranges used in this investigation 
can be applied during batch production. However, as already 
discussed, the variables Hardness, Relative Hardness Variation, and 
Weight Variation are impacted by the factors of Main Compression 
Force and/or FOM Speed. 
At the end of this study, it can be verified that the ranges of the 
factors Main Compression Force of 6 to 9 kN, Pre-Compression Force 
of 1,965 to 5,615 kN, and 55 RPM of FOM Speed, are responsible for 
all the attributes of analyzed qualities to remain within the 
specification expected. Comparing with other authors who carried 
out a similar investigation in the compression stage [12], it is 
observed that our study found some different results, mainly in the 
responses of Friability and Disintegration Time. As briefly discussed 
earlier, the force ranges used in this work, added to the intrinsic 
characteristics of our formulation, may have led to the behavior 
observed.
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The results of this investigation show that it was possible to apply 
the Design of Experiment (DoE) methodology in the compression 
process of the drug Albendazole 400 mg and to assess the impact of 
the parameters on this tablet production phase. Such knowledge was 
fundamental for a better understanding of the intrinsic 
characteristics of our formulation as well as the equipment used. 
This study showed that the values of the parameters Main 
Compression Force between 6 to 9 kN, Pre-Compression Force from 
1.965 to 5.615 kN, and 55 RPM of FOM Speed at a compression 
speed set at 63 RPM, config. a safe and reliable working range for 
routine production of the product studied, in addition to 
significantly increasing the productivity since the usual speed of 
production is about 6 times lower than that tested in this article. The 
FOM Speed parameter was the main control factor to maintain 
quality attributes. In a future investigation, the use of alternative 
tablet press speed ranges and FOM speeds can be studied in order to 
further optimize the production process. 
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